ClinConnect ClinConnect Logo
Search / Trial NCT03476941

Antibiotic Irrigations for Intra-Abdominal Drains

Launched by PAOLO GOFFREDO · Mar 22, 2018

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the best way to treat intra-abdominal abscesses, which are pockets of infection in the abdomen that can be drained to help the body heal. Currently, doctors use a combination of draining the abscess and giving antibiotics through the bloodstream. In this trial, researchers want to see if flushing the drain with a stronger antibiotic solution instead of regular saline (saltwater) can improve healing. The antibiotics being tested are Gentamicin and Clindamycin.

To participate in this trial, individuals must be between the ages of 65 and 74 or 29 and 219, have an intra-abdominal abscess that can be drained with a catheter, and be receiving systemic antibiotics. Participants will receive either the stronger antibiotic solution or normal saline through their drains. The trial is currently looking for volunteers, and it’s important for potential participants to understand that this study aims to find a better treatment option for abscesses, which could lead to improved recovery for patients in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Intra-abdominal abscess drained with catheter/drain
  • Treatment with systemic antibiotics
  • Able to consent
  • Exclusion Criteria:
  • Abscess(es) not amendable for an image guided drain placement.

About Paolo Goffredo

Paolo Goffredo is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on ethical practices and regulatory compliance, Goffredo specializes in designing and executing clinical trials across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals, researchers, and regulatory bodies to ensure the highest standards of quality and safety in its trials. By leveraging cutting-edge technologies and methodologies, Paolo Goffredo aims to contribute to the development of new therapies and enhance the understanding of complex medical conditions.

Locations

Iowa City, Iowa, United States

Patients applied

0 patients applied

Trial Officials

Paolo Goffredo, MD

Principal Investigator

University of Iowa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials